JAAPA CME Post-Test June 2018
Hypertension Guideline Update: A New Guideline for a New Era | Preparing Patients for Biologic Medications for Dermatologic and Rheumatic Diseases
Member: Free | Nonmember: $25

Hypertension Guideline Update: A New Guideline for a New Era

Sondra M. DePalma, MHS, PA-C, CLS, CHC, DFAAPA, AACC; Cheryl Dennison Himmelfarb, RN, ANP, PhD, FAHA, FPCNA, FAAN; Eric J. MacLaughlin, PharmD, FCCP, FASHP, BCPS; Sandra J. Taler, MD, FAHA, FACP

In the United States, hypertension affects about one-third of adults and contributes to one out of every seven deaths. Evidence-based treatment is associated with reductions in incidence of stroke, myocardial infarction, and heart failure as well as associated disability and death. This activity reviews the ACC/AHA Task Force on Clinical Practice Guidelines’ 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Key changes include reclassification of BP stages and lowering of hypertension treatment goals.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Compare and contrast the JNC 7 and 2017 guidelines for the diagnosis and management of hypertension.
  • List the stages of hypertension and their corresponding treatment recommendations.

Preparing Patients for Biologic Medications for Dermatologic and Rheumatic Diseases

Benjamin J. Smith, PA-C, DFAAPA; Brigitta C. Nuccio, MPAS, PA-C; Katelyn Y. Graves, PhD; Victor M. McMillan, MD, FACP, FACR

Psoriasis, psoriatic arthritis, and rheumatoid arthritis are prevalent conditions that often require a team of primary care and specialist healthcare professionals for the most optimum patient outcomes. Primary care providers can facilitate referrals to dermatology and rheumatology specialists by obtaining the needed screening workup for patients who need treatment with immunosuppressive therapies.This activity reviews tuberculosis screening, hepatitis screening, and vaccinations to be administered before patients begin biologic medications.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Describe the steps required to prepare a patient to begin therapy with a biologic or small-molecule medication.
  • List the screening studies and vaccinations that should be considered before starting a patient on a biologic or small-molecule medication.

Accreditation Statement


This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation. Approval is valid through June 30, 2019. 

Disclosure Policy Statement

It is the policy of AAPA to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member has with the commercial interest of any commercial product discussed in an educational presentation. The participating faculty reported the following:

Sondra M. DePalma practices at PinnacleHealth CardioVascular Institute in Harrisburg, Pa., and is director of regulatory and professional practice for the American Academy of PAs in Alexandria, Va. Cheryl Dennison Himmelfarb is a professor and associate dean for research at Johns Hopkins University School of Nursing in Baltimore, Md. Eric J. MacLaughlin is a professor and chair of the Department of Pharmacy Practice at Texas Tech University Health Sciences Center’s School of Pharmacy in Amarillo, Tex. Sandra J. Taler is a staff consultant in the Division of Nephrology/Hypertension and a professor of medicine at the Mayo Clinic College of Medicine in Rochester, Minn. Acknowledgment: The authors of Hypertension Guideline Update: A New Guideline for a New Era would like to thank Paul K. Whelton, MB, MD, MSc, FAHA, and Robert M. Carey, MD, FAHA, for their assistance with this manuscript. In the PA program at Florida State University in Tallahassee, Benjamin J. Smith is director of didactic education and Brigitta C. Nuccio and Katelyn Y. Graves are assistant professors. Victor M. McMillan practices at McIntosh Clinic in Thomasville, Ga. Acknowledgment: The authors of Preparing Patients for Biologic Medications for Dermatologic and Rheumatic Diseases wish to thank Mark E. Archambault, DHSc, PA-C, for his assistance with this manuscript. The authors have disclosed no potential conflicts of interest, financial or otherwise.

AAPA offers no returns or refunds for online CME activities purchased through the AAPA store. All sales are final.


Type:     Journal-based CME
3550 Registered Users